{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T09:21:10Z","timestamp":1761211270549,"version":"build-2065373602"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,23]]},"DOI":"10.7759\/cureus.95208","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T09:16:30Z","timestamp":1761210990000},"source":"Crossref","is-referenced-by-count":0,"title":["Analysis of Risk Scoring for Placenta Accreta Spectrum and Its Impact on Maternal and Fetal Outcomes"],"prefix":"10.7759","author":[{"given":"Komal P","family":"Raut","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sornam","family":"MS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasmine Kavitha","family":"Washington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2005.06.037","article-title":"Placenta previa-accreta: risk factors and complications","volume":"193","author":"Usta IM","year":"2005","unstructured":"Usta IM, Hobeika EM, Musa AA, Gabriel GE, Nassar AH. Placenta previa-accreta: risk factors and complications. Am J Obstet Gynecol. 2005, 193:1045-9. 10.1016\/j.ajog.2005.06.037","journal-title":"Am J Obstet Gynecol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0052893","article-title":"Incidence and risk factors for placenta accreta\/increta\/percreta in the UK: a national case-control study","volume":"7","author":"Fitzpatrick KE","year":"2012","unstructured":"Fitzpatrick KE, Sellers S, Spark P, Kurinczuk JJ, Brocklehurst P, Knight M. Incidence and risk factors for placenta accreta\/increta\/percreta in the UK: a national case-control study. PLoS One. 2012, 7:52893. 10.1371\/journal.pone.0052893","journal-title":"PLoS One"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.13547","article-title":"Abnormally invasive placenta-prevalence, risk factors and antenatal suspicion: results from a large population-based pregnancy cohort study in the Nordic countries","volume":"123","author":"Thurn L","year":"2016","unstructured":"Thurn L, Lindqvist PG, Jakobsson M, et al.. Abnormally invasive placenta-prevalence, risk factors and antenatal suspicion: results from a large population-based pregnancy cohort study in the Nordic countries. BJOG. 2016, 123:1348-55. 10.1111\/1471-0528.13547","journal-title":"BJOG"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2011.06.035","article-title":"Impact of multiple cesarean deliveries on maternal morbidity: a systematic review","volume":"205","author":"Marshall NE","year":"2011","unstructured":"Marshall NE, Fu R, Guise JM. Impact of multiple cesarean deliveries on maternal morbidity: a systematic review. Am J Obstet Gynecol. 2011, 205:262.e1-8. 10.1016\/j.ajog.2011.06.035","journal-title":"Am J Obstet Gynecol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000292082.80566.cd","article-title":"Pregnancy outcomes for women with placenta previa in relation to the number of prior cesarean deliveries","volume":"110","author":"Grobman WA","year":"2007","unstructured":"Grobman WA, Gersnoviez R, Landon MB, et al.. Pregnancy outcomes for women with placenta previa in relation to the number of prior cesarean deliveries. Obstet Gynecol. 2007, 110:1249-55. 10.1097\/01.AOG.0000292082.80566.cd","journal-title":"Obstet Gynecol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000003970","article-title":"Placenta accreta spectrum without placenta previa","volume":"136","author":"Carusi DA","year":"2020","unstructured":"Carusi DA, Fox KA, Lyell DJ, et al.. Placenta accreta spectrum without placenta previa. Obstet Gynecol. 2020, 136:458-65. 10.1097\/AOG.0000000000003970","journal-title":"Obstet Gynecol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-88551-7","article-title":"Antenatal diagnosis of placenta accreta spectrum after in vitro fertilization-embryo transfer: a systematic review and meta-analysis","volume":"11","author":"Matsuzaki S","year":"2021","unstructured":"Matsuzaki S, Nagase Y, Takiuchi T, et al.. Antenatal diagnosis of placenta accreta spectrum after in vitro fertilization-embryo transfer: a systematic review and meta-analysis. Sci Rep. 2021, 11:9205. 10.1038\/s41598-021-88551-7","journal-title":"Sci Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2020.04.026","article-title":"In\u00a0vitro fertilization as an independent risk factor for placenta accreta spectrum","volume":"223","author":"Salmanian B","year":"2020","unstructured":"Salmanian B, Fox KA, Arian SE, et al.. In\u00a0vitro fertilization as an independent risk factor for placenta accreta spectrum. Am J Obstet Gynecol. 2020, 223:568.e1-5. 10.1016\/j.ajog.2020.04.026","journal-title":"Am J Obstet Gynecol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.15227","article-title":"Are singleton pregnancies after assisted reproduction technology (ART) associated with a higher risk of placental anomalies compared with non-ART singleton pregnancies? A systematic review and meta-analysis","volume":"126","author":"Vermey BG","year":"2019","unstructured":"Vermey BG, Buchanan A, Chambers GM, Kolibianakis EM, Bosdou J, Chapman MG, Venetis CA. Are singleton pregnancies after assisted reproduction technology (ART) associated with a higher risk of placental anomalies compared with non-ART singleton pregnancies? A systematic review and meta-analysis. BJOG. 2019, 126:209-18. 10.1111\/1471-0528.15227","journal-title":"BJOG"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2018.33.e234","article-title":"Women with endometriosis, especially those who conceived with assisted reproductive technology, have increased risk of placenta previa: meta-analyses","volume":"33","author":"Jeon H","year":"2018","unstructured":"Jeon H, Min J, Kim DK, Seo H, Kim S, Kim YS. Women with endometriosis, especially those who conceived with assisted reproductive technology, have increased risk of placenta previa: meta-analyses. J Korean Med Sci. 2018, 33:234. 10.3346\/jkms.2018.33.e234","journal-title":"J Korean Med Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/s0015-0282(03)00793-3","article-title":"High frequency of cesarean section, antepartum hemorrhage, placenta previa, and preterm delivery in in-vitro fertilization twin pregnancies","volume":"80","author":"Smithers PR","year":"2003","unstructured":"Smithers PR, Halliday J, Hale L, Talbot JM, Breheny S, Franzcog DH. High frequency of cesarean section, antepartum hemorrhage, placenta previa, and preterm delivery in in-vitro fertilization twin pregnancies.  Fertil Steril. 2003, 80:666-8. 10.1016\/s0015-0282(03)00793-3","journal-title":"Fertil Steril"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1159\/000492829","article-title":"Second trimester biochemical markers as possible predictors of pathological placentation: a retrospective case-control study","volume":"46","author":"Berezowsky A","year":"2019","unstructured":"Berezowsky A, Pardo J, Ben-Zion M, Wiznitzer A, Aviram A. Second trimester biochemical markers as possible predictors of pathological placentation: a retrospective case-control study. Fetal Diagn Ther. 2019, 46:187-92. 10.1159\/000492829","journal-title":"Fetal Diagn Ther"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.18821\/0869-2084-2020-65-6-353-357","article-title":"Prognostic significance of specific proteins of pregnancy in women with a uterine scar and placenta accreta (Article in Russian)","volume":"65","author":"Borovkov VA","year":"2020","unstructured":"Borovkov VA, Igitova MB, Korenovskiy YV, Dudareva YA. Prognostic significance of specific proteins of pregnancy in women with a uterine scar and placenta accreta (Article in Russian). Klin Lab Diagn. 2020, 65:353-7. 10.18821\/0869-2084-2020-65-6-353-357","journal-title":"Klin Lab Diagn"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/1507674","article-title":"Placenta accreta spectrum: a review of pathology, molecular biology, and biomarkers","volume":"2018","author":"Bartels HC","year":"2018","unstructured":"Bartels HC, Postle JD, Downey P, Brennan DJ. Placenta accreta spectrum: a review of pathology, molecular biology, and biomarkers. Dis Markers. 2018, 2018:1507674. 10.1155\/2018\/1507674","journal-title":"Dis Markers"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.13298","article-title":"First trimester maternal serum biochemical markers of aneuploidy in pregnancies with abnormally invasive placentation","volume":"122","author":"Thompson O","year":"2015","unstructured":"Thompson O, Otigbah C, Nnochiri A, Sumithran E, Spencer K. First trimester maternal serum biochemical markers of aneuploidy in pregnancies with abnormally invasive placentation. BJOG. 2015, 122:1370-6. 10.1111\/1471-0528.13298","journal-title":"BJOG"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2018.09.042","article-title":"Placenta accreta spectrum","volume":"219","author":"Cahill AG","year":"2018","unstructured":"Cahill AG, Beigi R, Heine RP, Silver RM, Wax JR. Placenta accreta spectrum. Am J Obstet Gynecol. 2018, 219:2-16. 10.1016\/j.ajog.2018.09.042","journal-title":"Am J Obstet Gynecol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/jum.15530","article-title":"Predicting placenta accreta spectrum: validation of the placenta accreta index","volume":"40","author":"Happe SK","year":"2021","unstructured":"Happe SK, Yule CS, Spong CY, et al.. Predicting placenta accreta spectrum: validation of the placenta accreta index. J Ultrasound Med. 2021, 40:1523-32. 10.1002\/jum.15530","journal-title":"J Ultrasound Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.55489\/njcm.160520255339","article-title":"B.G. Prasad scale 2025: an updated framework for socioeconomic assessment in India","volume":"16","author":"Anand A","year":"2025","unstructured":"Anand A, Mandal I, Hossain S. B.G. Prasad scale 2025: an updated framework for socioeconomic assessment in India. Natl J Community Med. 2025, 16:555-8. 10.55489\/njcm.160520255339","journal-title":"Natl J Community Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-023-05886-x","article-title":"Ultrasound scoring system for prenatal diagnosis of placenta accreta spectrum","volume":"23","author":"Zhang J","year":"2023","unstructured":"Zhang J, Li H, Feng D, Wu J, Wang Z, Feng F. Ultrasound scoring system for prenatal diagnosis of placenta accreta spectrum. BMC Pregnancy Childbirth. 2023, 23:569. 10.1186\/s12884-023-05886-x","journal-title":"BMC Pregnancy Childbirth"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/FM9.0000000000000183","article-title":"High risk factors for placenta accreta other than pregnancy and their impact on patient prognosis","volume":"5","author":"Yang X","year":"2023","unstructured":"Yang X, Zheng W, Yan J, Yang H. High risk factors for placenta accreta other than pregnancy and their impact on patient prognosis. Matern Fetal Med. 2023, 5:137-43. 10.1097\/FM9.0000000000000183","journal-title":"Matern Fetal Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.25122\/jml-2021-0134","article-title":"Maternal and fetal outcome in placenta accreta spectrum (PAS) associated with placenta previa: a retrospective analysis from a tertiary center","volume":"14","author":"Varlas VN","year":"2021","unstructured":"Varlas VN, Bors RG, Birsanu S, Maxim B, Clotea E, Mihailov M. Maternal and fetal outcome in placenta accreta spectrum (PAS) associated with placenta previa: a retrospective analysis from a tertiary center. J Med Life. 2021, 14:367-75. 10.25122\/jml-2021-0134","journal-title":"J Med Life"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-023-05784-2","article-title":"Screening of placenta accreta spectrum disorder using maternal serum biomarkers and clinical indicators:\u00a0a case-control study","volume":"23","author":"Zhou J","year":"2023","unstructured":"Zhou J, Yang S, Xu X, et al.. Screening of placenta accreta spectrum disorder using maternal serum biomarkers and clinical indicators:\u00a0a case-control study. BMC Pregnancy Childbirth. 2023, 23:508. 10.1186\/s12884-023-05784-2","journal-title":"BMC Pregnancy Childbirth"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.862785","article-title":"Placenta accreta spectrum among multiple gestation: a retrospective analysis based on a Chinese population","volume":"13","author":"Guo Z","year":"2022","unstructured":"Guo Z, Han X, Zheng W, Yang H, Ma J. Placenta accreta spectrum among multiple gestation: a retrospective analysis based on a Chinese population. Front Endocrinol (Lausanne). 2022, 13:862785. 10.3389\/fendo.2022.862785","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/423589-analysis-of-risk-scoring-for-placenta-accreta-spectrum-and-its-impact-on-maternal-and-fetal-outcomes","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T09:16:31Z","timestamp":1761210991000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/423589-analysis-of-risk-scoring-for-placenta-accreta-spectrum-and-its-impact-on-maternal-and-fetal-outcomes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,23]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.95208","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,23]]}}}